F-group (family)
235.1.1.15 Cytochrom_B562
Ligands and drugs
216
Member domains
30
with ligand contacts (≤ 4 Å)
13.9% of members
5
with DrugDomain annotations
2.3% of members
3
with a DrugBank compound
1.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 235.1.1.15 belongs to X-group 235 Lysozyme-like, which binds 11.0 ligand superclasses per 20 proteins, broader than 98% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB11315 | 3C0 | Methscopolamine | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 13 |
| OLA | OLEIC ACID | 4 |
| EBX | 4-[[3,4-bis(oxidanylidene)-2-[[(1~{R})-1-(4-propan-2-ylfuran-2-yl)propyl]amino]cyclobuten-1-yl]amino]-~{N},~{N}-dimethyl-3-oxidanyl-pyridine-2-carboxamide | 2 |
| NKP | (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate | 2 |
| A1CH1 | 4-[(2-{[(R)-(1,4-dimethyl-1H-pyrazol-3-yl)(1-methylcyclopentyl)methyl]amino}-3,4-dioxocyclobut-1-en-1-yl)amino]-3-hydroxy-N,N-dimethylpyridine-2-carboxamide | 1 |
| A1D5I | Macitentan | 1 |
| A1D5J | Ambrisentan | 1 |
| A1D5L | Zibotentan | 1 |
| A1L10 | 1-[(4-fluorophenyl)methyl]-1-[(8~{S})-5-methyl-5-azaspiro[2.5]octan-8-yl]-3-[[4-(2-methylpropoxy)phenyl]methyl]urea | 1 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 1 |
| CAmetal | CALCIUM ION | 1 |
| NAmetal | SODIUM ION | 1 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 1 |
| P15 | 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL | 1 |
| X7T | 1-{2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-3-{[(3R)-oxolan-3-yl]amino}-7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl}ethan-1-one | 1 |
| XY8 | 3-{4-[(2,4-difluorophenyl)methyl]piperazin-1-yl}-7-methyl-N-(propan-2-yl)pyrido[3,4-b]pyrazin-2-amine | 1 |